INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo THROMBOPHOB GEL

SCHEDULING STATUS
S1

PROPRIETARY NAME
(and dosage form)

THROMBOPHOB GEL

COMPOSITION
Per 100 g clear gel:
Heparin sodium equivalent to Heparin 20 000 i.u.

PHARMACOLOGICAL CLASSIFICATION
A 13.9 Dermatological preparations, special combinations

PHARMACOLOGICAL ACTION
THROMBOPHOB GEL is a novel form of heparin therapy for topical application. The glass-clear gel is distinguished, in particular, by its ability to penetrate pathologically altered tissue immediately upon application without leaving residues or degreasing the skin.
The properties and mode of action of natural heparin offer all the prerequisites necessary for effective therapy of thrombophlebitis occurring close to the skin and of other superficial inflammations.
Heparin assists in strengthening and supporting the connective tissues. Scar tissue becomes soft and regains elasticity and strength.
Heparin also has an antiphlogistic and anti-exudative effect, thus alleviating pain and promoting tissue metabolism and the process of healing.

INDICATIONS
Circulatory disorders
Superficial phlebitis and thrombophlebitis
Varicose veins, indolent ulcers and bed sores
External haemorrhoids
Accidents and injuries
Sprains, strains, contusions and grass burns
Haematomas
Scar tissue (to prevent formation of keloid tissue)

CONTRA-INDICATIONS
No specific contra-indications are known

WARNINGS
For external use only

DOSAGE AND DIRECTIONS FOR USE
THROMBOPHOB GEL should be applied in a thin layer to the skin of the affected part and its surrounds, two to three times a day.
The gel need not be rubbed or massaged into the skin. It is completely absorbed by the skin in a short time without leaving sticky or greasy residues.
The cooling effect of the gel adds to a pleasant sensation when it is applied.

SIDE-EFFECTS AND SPECIAL PRECAUTIONS
No allergic or any other adverse reactions have been reported and there are no special precautions, but contact with the eyes should be avoided. No control tests need be carried out. In the case of open wounds, THROMBOPHOB GEL should be applied around the fringes of the wound and not on the wound itself.

KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT
None reported

IDENTIFICATION
Clear, transparent gel

PRESENTATION
Tubes of 25 g

STORAGE INSTRUCTIONS
Store below 25°C.
KEEP OUT OF REACH OF CHILDREN.

REFERENCE NUMBER
G1635 (Act 101/1965)

NAME AND BUSINESS ADDRESS OF THE APPLICANT
NORISTAN LIMITED
326 MARKS STREET, WALTLOO, PRETORIA

DATE OF PUBLICATION OF THIS PACKAGE INSERT
31 March 1995

NORISTAN LABORATORIES
Division of
NORISTAN LIMITED, WALTLOO, PRETORIA
Under licence to Nordmark-Werke GmbH, Hamburg, Germany

D 193/012

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2000